Cargando…
The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate
The respiratory organ serves as a primary target site for SARS-CoV-2. Thus, the vaccine-stimulating immune response of the respiratory tract is significant in controlling SARS-CoV-2 transmission and disease development. In this study, mucoadhesive nanoparticles were used to deliver SARS-CoV-2 spike...
Autores principales: | Jearanaiwitayakul, Tuksin, Limthongkul, Jitra, Kaofai, Chernkhwan, Apichirapokey, Suttikarn, Chawengkirttikul, Runglawan, Sapsutthipas, Sompong, Sunintaboon, Panya, Ubol, Sukathida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138454/ https://www.ncbi.nlm.nih.gov/pubmed/35625879 http://dx.doi.org/10.3390/biomedicines10051142 |
Ejemplares similares
-
Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2021) -
Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2021) -
The Adjuvant Activity of BCG Cell Wall Cytoskeleton on a Dengue Virus-2 Subunit Vaccine
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2023) -
Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination
por: Nantachit, Nattika, et al.
Publicado: (2016) -
Immunogenic Properties of a BCG Adjuvanted Chitosan Nanoparticle-Based Dengue Vaccine in Human Dendritic Cells
por: Hunsawong, Taweewun, et al.
Publicado: (2015)